Allergy Therapeutics plc
AGY.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£39,200 | -£40,216 | -£43,071 | -£13,776 |
| Dep. & Amort. | £4,172 | £4,319 | £4,224 | £4,166 |
| Deferred Tax | £0 | £0 | -£547 | -£14,686 |
| Stock-Based Comp. | £871 | £0 | £114 | £469 |
| Change in WC | -£3,334 | -£1,095 | £8,015 | -£5,885 |
| Other Non-Cash | £8,774 | £4,854 | £349 | £15,601 |
| Operating Cash Flow | -£28,717 | -£32,138 | -£30,916 | -£14,111 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£3,422 | -£3,401 | -£4,669 | -£3,056 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | -£159 | -£179 |
| Inv. Sales/Matur. | £267 | £2,067 | £0 | £0 |
| Other Inv. Act. | £0 | £135 | £159 | £179 |
| Investing Cash Flow | -£3,155 | -£1,199 | -£4,669 | -£3,056 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £34,676 | £32,573 | £25,039 | -£957 |
| Stock Issued | £0 | £2,417 | £6,489 | £3 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£2,636 | -£2,497 | -£1,615 | -£1,684 |
| Financing Cash Flow | £32,040 | £31,431 | £29,913 | -£2,638 |
| Forex Effect | -£293 | -£24 | £2 | £47 |
| Net Chg. in Cash | -£125 | -£1,930 | -£5,670 | -£19,758 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £12,915 | £14,845 | £20,515 | £40,273 |
| End Cash | £12,790 | £12,915 | £14,845 | £20,515 |
| Free Cash Flow | -£31,981 | -£35,539 | -£35,585 | -£17,167 |